CD1A
Basic information
Region (hg38): 1:158254424-158258269
Previous symbols: [ "CD1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CD1A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 30 | 36 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 2 | |||
non coding | 0 | |||||
Total | 0 | 0 | 30 | 5 | 1 |
Variants in CD1A
This is a list of pathogenic ClinVar variants found in the CD1A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-158255188-C-G | not specified | Uncertain significance (Jul 19, 2022) | ||
1-158255189-A-T | not specified | Uncertain significance (Nov 21, 2024) | ||
1-158255204-A-G | not specified | Uncertain significance (Jun 28, 2022) | ||
1-158255218-G-A | not specified | Likely benign (Jul 14, 2022) | ||
1-158255260-G-A | not specified | Uncertain significance (Sep 01, 2021) | ||
1-158255263-T-C | not specified | Uncertain significance (Sep 06, 2022) | ||
1-158255277-A-T | not specified | Uncertain significance (Apr 22, 2024) | ||
1-158255285-T-C | not specified | Uncertain significance (Nov 08, 2024) | ||
1-158255293-C-T | Benign (Jun 30, 2017) | |||
1-158255302-C-T | not specified | Uncertain significance (Jun 13, 2022) | ||
1-158255320-C-T | not specified | Uncertain significance (Jul 02, 2024) | ||
1-158255329-G-A | not specified | Uncertain significance (Oct 25, 2022) | ||
1-158256097-T-C | not specified | Uncertain significance (Feb 28, 2023) | ||
1-158256099-G-C | not specified | Likely benign (Feb 08, 2023) | ||
1-158256175-A-G | not specified | Uncertain significance (Oct 25, 2022) | ||
1-158256185-G-C | not specified | Uncertain significance (Aug 27, 2024) | ||
1-158256231-C-T | not specified | Uncertain significance (May 09, 2023) | ||
1-158256232-G-A | not specified | Uncertain significance (Oct 22, 2021) | ||
1-158256265-C-A | not specified | Uncertain significance (Aug 26, 2024) | ||
1-158256277-G-A | not specified | Uncertain significance (Dec 19, 2022) | ||
1-158256783-C-T | Benign (Jun 30, 2017) | |||
1-158256857-T-G | not specified | Uncertain significance (May 24, 2024) | ||
1-158256899-G-A | not specified | Uncertain significance (Aug 07, 2024) | ||
1-158256900-G-A | Likely benign (Aug 15, 2018) | |||
1-158256920-A-C | not specified | Uncertain significance (Oct 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CD1A | protein_coding | protein_coding | ENST00000289429 | 6 | 4133 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.20e-24 | 0.00000598 | 125522 | 0 | 224 | 125746 | 0.000891 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.611 | 215 | 191 | 1.12 | 0.0000108 | 2138 |
Missense in Polyphen | 77 | 67.045 | 1.1485 | 767 | ||
Synonymous | -1.01 | 82 | 71.2 | 1.15 | 0.00000379 | 633 |
Loss of Function | -2.50 | 29 | 17.7 | 1.64 | 8.38e-7 | 188 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00862 | 0.00865 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000326 | 0.000326 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000160 | 0.000158 |
Middle Eastern | 0.000326 | 0.000326 |
South Asian | 0.000163 | 0.000163 |
Other | 0.00376 | 0.00375 |
dbNSFP
Source:
- Function
- FUNCTION: Antigen-presenting protein that binds self and non-self lipid and glycolipid antigens and presents them to T-cell receptors on natural killer T-cells. {ECO:0000269|PubMed:11231314, ECO:0000269|PubMed:16272286, ECO:0000269|PubMed:18178838}.;
- Pathway
- Tight junction - Homo sapiens (human);Hematopoietic cell lineage - Homo sapiens (human);Immune System;Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell;Adaptive Immune System
(Consensus)
Recessive Scores
- pRec
- 0.264
Intolerance Scores
- loftool
- 0.933
- rvis_EVS
- 0.11
- rvis_percentile_EVS
- 62
Haploinsufficiency Scores
- pHI
- 0.0771
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.502
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0218
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- positive regulation of T cell mediated cytotoxicity;adaptive immune response;immune response;antigen processing and presentation, endogenous lipid antigen via MHC class Ib;antigen processing and presentation, exogenous lipid antigen via MHC class Ib;regulation of immune response
- Cellular component
- extracellular space;plasma membrane;integral component of plasma membrane;external side of plasma membrane;endosome membrane;membrane raft
- Molecular function
- protein binding;endogenous lipid antigen binding;exogenous lipid antigen binding;lipopeptide binding